Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
ArriVent BioPharma (AVBP) Reiterated at Overweight by Cantor Fitzgerald
-
Bicara Therapeutics (BCAX) Reiterated at Overweight by Cantor Fitzgerald
-
ArriVent BioPharma (AVBP) Reiterated at Overweight by Cantor Fitzgerald
-
Cantor Fitzgerald Starts Odyssey Therapeutics (ODTX) at Overweight
-
Cantor Fitzgerald Starts Rare Earths Americas (REA) at Spec. Buy
-
Form 4 NEWMARK GROUP, INC. For: May 28 Filed by: CANTOR FITZGERALD, L. P.
-
Form NPORT-P CANTOR FITZGERALD INFRAS For: Mar 31
-
Osisko Development Announces Closings of Additional US$75 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes Bringing Total Offering to US$300 Million
-
CrowdStrike Holdings (CRWD) Reiterated at Overweight by Cantor Fitzgerald
-
OpenPayd to go public via SPAC merger at $1.145 billion valuation
-
Pfizer (PFE) Reiterates at Neutral by Cantor Fitzgerald
-
OpenPayd Targets Nasdaq Listing at Unicorn Valuation
-
Zscaler (ZS) PT Lowered to $225 at Cantor Fitzgerald on 'Cautious FY27 Setup'
-
Summit Therapeutics (SMMT) Reiterated at Overweight by Cantor Fitzgerald
-
Cullen/Frost Bankers (CFR) Reiterated at Neutral by Cantor Fitzgerald
-
Rubrik (RBRK) Reiterated at Overweight by Cantor Fitzgerald Before Earnings
-
SailPoint Technologies (SAIL) Reiterated at Overweight by Cantor Fitzgerald
-
Tesla (TSLA) Reiterated at Overweight by Cantor Fitzgerald
-
OpenPayd to merge with Titan SPAC for $1.145 billion valuation
-
OpenPayd Targets Nasdaq Listing at Unicorn Valuation
-
Form NPORT-P Cantor Fitzgerald Variab For: Mar 31
-
Aligos Therapeutics (ALGS) Reiterated at Overweight by Cantor Fitzgerald
-
Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald
-
ARS Pharmaceuticals Inc (SPRY) PT Raised to $30 at Cantor Fitzgerald
-
Dycom Industries (DY) PT Raised to $654 at Cantor Fitzgerald on Q1 Beat
-
Elastic NV. (ESTC) Reiterated at Neutral by Cantor Fitzgerald
-
SentinelOne (S) Reiterated at Overweight by Cantor Fitzgerald After Solid Q1 Results
-
Okta, Inc (OKTA) PT Raised to $125 at Cantor Fitzgerald After Q1 Beat-&-Raise
-
MongoDB (MDB) Reiterated at Overweight by Cantor Fitzgerald
-
Cantor Fitzgerald Starts Sensei Biotherapeutics (SNSE) at Overweight
-
Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
-
Marvell (MRVL) PT Raised to $220 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Braze Inc (BRZE)
-
Cantor Fitzgerald Reiterates Overweight Rating on salesforce.com (CRM)
-
Snowflake Inc. (SNOW) PT Raised to $282 at Cantor Fitzgerald
-
IREN Ltd. (IREN) PT Raised to $99 at Cantor Fitzgerald
-
WindRose Health Investors Completes Sale of Altruix to Frazier Healthcare Partners
-
Bicara Therapeutics (BCAX) Reiterated at Overweight by Cantor Fitzgerald
-
DeFi Development (DFDV) PT Raised to $7 at Cantor Fitzgerald
-
Zscaler (ZS) PT Lowered to $225 at Cantor Fitzgerald on Cautious Initial Fy27 Outlook
-
SentinelOne Inc (S) PT Raised to $24 at Cantor Fitzgerald Ahead of Q1 Earnings
-
Satellogic (SATL) Reiterated at Overweight by Cantor Fitzgerald
-
Intuitive Machines (LUNR) Reiterated at Overweight by Cantor Fitzgerald
-
Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald
-
Okta, Inc (OKTA) PT Raised to $110 at Cantor Fitzgerald
-
Pasqal files registration statement for SPAC merger with Bleichroeder
-
Pasqal and Bleichroeder Acquisition Corp. II Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination
-
Editas Medicine prices $125 million public offering of stock and warrants
-
Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering
-
Marti Technologies (MRT) PT Raised to $2.40 at Cantor Fitzgerald

